Hanlon Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,089
Closed -$205K 190
2024
Q3
$205K Buy
+7,089
New +$207K 0.06% 165
2024
Q2
Sell
-7,287
Closed -$202K 173
2024
Q1
$202K Buy
+7,287
New +$202K 0.06% 143
2023
Q1
Sell
-4,036
Closed -$207K 147
2022
Q4
$207K Buy
+4,036
New +$193K 0.07% 114
2022
Q3
Sell
-3,927
Closed -$206K 117
2022
Q2
$206K Buy
+3,927
New +$200K 0.05% 110
2022
Q1
Sell
-3,406
Closed -$201K 125
2021
Q4
$201K Buy
+3,406
New +$169K 0.04% 124
2021
Q3
Sell
-7,799
Closed -$305K 141
2021
Q2
$305K Sell
7,799
-2,461
-24% -$95.7K 0.06% 109
2021
Q1
$372K Buy
10,260
+45
+0.4% +$1.6K 0.08% 101
2020
Q4
$376K Sell
10,215
-741
-7% -$27.2K 0.08% 95
2020
Q3
$381K Buy
10,956
+337
+3% +$11.8K 0.12% 81
2020
Q2
$329K Buy
10,619
+40
+0.4% +$1.36K 0.1% 78
2020
Q1
$328K Sell
10,579
-113
-1% -$3.85K 0.21% 61
2019
Q4
$397K Buy
10,692
+36
+0.3% +$1.28K 0.08% 84
2019
Q3
$363K Sell
10,656
-10,579
-50% -$385K 0.09% 65
2019
Q2
$873K Buy
21,235
+691
+3% +$27.4K 0.06% 63
2019
Q1
$828K Buy
+20,544
New +$823K 0.09% 64
2017
Q2
Sell
-94,405
Closed -$3.06M 100
2017
Q1
$3.06M Buy
94,405
+84,133
+819% +$2.65M 0.38% 20
2016
Q4
$317K Hold
10,272
0.04% 115
2016
Q3
$330K Sell
10,272
-145,841
-93% -$4.88M 0.03% 41
2016
Q2
$5.21M Buy
156,113
+145,841
+1,420% +$4.65M 0.45% 24
2016
Q1
$289K Sell
10,272
-129,075
-93% -$3.69M 0.03% 63
2015
Q4
$4.27M Buy
139,347
+125,077
+877% +$3.93M 0.41% 25
2015
Q3
$425K Hold
14,270
0.82% 21
2015
Q2
$454K Hold
14,270
0.76% 21
2015
Q1
$471K Hold
14,270
0.34% 31
2014
Q4
$422K Buy
14,270
+5,875
+70% +$168K 0.3% 31
2014
Q3
$236K Buy
8,395
+657
+8% +$18.4K 0.78% 20
2014
Q2
$218K Buy
7,738
+31
+0.4% +$884 0.37% 29
2014
Q1
$235K Buy
7,707
+30
+0.4% +$894 0.11% 28
2013
Q4
$223K Buy
7,677
+27
+0.4% +$786 0.1% 18
2013
Q3
$208K Sell
7,650
-54
-0.7% -$1.47K 0.1% 27
2013
Q2
$205K Buy
+7,704
New +$213K 0.3% 14

Other funds holding PFE